Mannose ameliorates experimental colitis by protecting intestinal barrier integrity

• Published in: Nature communications Vol. 13; no. 1; p. 4804
• Main Authors: Dong, Lijun, Xie, Jingwen, Wang, Youyi, Jiang, Honglian, Chen, Kai, Li, Dantong, Wang, Jing, Liu, Yunzhi, He, Jia, Zhou, Jia, Zhang, Liyun, Lu, Xiao, Zou, Xiaoming, Wang, Xiang-Yang, Wang, Qingqing, Chen, Zhengliang, Zuo, Daming
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 16.08.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 13; 13/31; 13/51; 14; 14/1; 14/19; 38; 631/80/79; 692/4020/1503/257; 692/700; 82/51; Animal models; Cathepsin B; Colitis; Damage; Dextran; Dextrans; Epithelium; Glycoproteins; Health services; Humanities and Social Sciences; Inflammatory bowel disease; Inflammatory bowel diseases; Integrity; Interleukin 10; Intestine; Kinases; Mannose; Metabolites; Mitochondria; Monosaccharides; multidisciplinary; Myosin; Myosin-light-chain kinase; Pathogenesis; Patients; Science; Science (multidisciplinary); Sodium sulfate; Supplements
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-32505-8

Metabolite alteration has been associated with the pathogenesis of inflammatory bowel disease (IBD), including colitis. Mannose, a natural bioactive monosaccharide that is involved in metabolism and synthesis of glycoproteins, exhibits anti-inflammatory and anti-oxidative activities. We show here that the circulating level of mannose is increased in patients with IBD and mice with experimental colitis. Mannose treatment attenuates intestinal barrier damage in two mouse colitis models, dextran sodium sulfate (DSS)-induced colitis and spontaneous colitis in IL-10 -deficient mice. We demonstrate that mannose treatment enhanced lysosomal integrity and limited the release of cathepsin B, preventing mitochondrial dysfunction and myosin light chain kinase (MLCK)-induced tight junction disruption in the context of intestinal epithelial damage. Mannose exerts a synergistic therapeutic effect with mesalamine on mouse colitis. Cumulatively, the results indicate that mannose supplementation may be an optional approach to the treatment of colitis and other diseases associated with intestinal barrier dysfunction. New potential therapies for inflammatory bowel disease are needed as not all patients respond to or maintain a response to conventional therapies. Here the authors report that mannose supplementation ameliorates experimental colitis in male mice, potentially via effects on intestinal epithelium lysosomal integrity.